View in EDS HTML Full Text PDF Full Text

A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.

Saved in:
Bibliographic Details
Title: A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
Authors: Ing SW; Division of Endocrinology, Diabetes, and Metabolism Ohio State University Wexner Medical Center Columbus OH USA., Finkelman RD; Takeda Pharmaceuticals USA, Inc. Lexington MA USA., He P; Takeda Pharmaceuticals USA, Inc. Lexington MA USA., Khan AA; Divisions of Endocrinology and Metabolism and Geriatrics McMaster University Oakville ON Canada., Mannstadt M; Endocrine Unit Massachusetts General Hospital and Harvard Medical School Boston MA USA., Rejnmark L; Department of Clinical Medicine - Department of Endocrinology and Internal Medicine Aarhus University and Aarhus University Hospital Aarhus Denmark., Song I; Takeda Pharmaceuticals USA, Inc. Lexington MA USA., Takács I; Department of Internal Medicine and Oncology Semmelweis University Budapest Hungary., Wu Y; Takeda Pharmaceuticals USA, Inc. Lexington MA USA.
Source: JBMR plus [JBMR Plus] 2023 May 31; Vol. 7 (7), pp. e10758. Date of Electronic Publication: 2023 May 31 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101707013 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4039 (Electronic) Linking ISSN: 24734039 NLM ISO Abbreviation: JBMR Plus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37457880
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ing+SW%22">Ing SW</searchLink>; Division of Endocrinology, Diabetes, and Metabolism Ohio State University Wexner Medical Center Columbus OH USA.<br /><searchLink fieldCode="AU" term="%22Finkelman+RD%22">Finkelman RD</searchLink>; Takeda Pharmaceuticals USA, Inc. Lexington MA USA.<br /><searchLink fieldCode="AU" term="%22He+P%22">He P</searchLink>; Takeda Pharmaceuticals USA, Inc. Lexington MA USA.<br /><searchLink fieldCode="AU" term="%22Khan+AA%22">Khan AA</searchLink>; Divisions of Endocrinology and Metabolism and Geriatrics McMaster University Oakville ON Canada.<br /><searchLink fieldCode="AU" term="%22Mannstadt+M%22">Mannstadt M</searchLink>; Endocrine Unit Massachusetts General Hospital and Harvard Medical School Boston MA USA.<br /><searchLink fieldCode="AU" term="%22Rejnmark+L%22">Rejnmark L</searchLink>; Department of Clinical Medicine - Department of Endocrinology and Internal Medicine Aarhus University and Aarhus University Hospital Aarhus Denmark.<br /><searchLink fieldCode="AU" term="%22Song+I%22">Song I</searchLink>; Takeda Pharmaceuticals USA, Inc. Lexington MA USA.<br /><searchLink fieldCode="AU" term="%22Takács+I%22">Takács I</searchLink>; Department of Internal Medicine and Oncology Semmelweis University Budapest Hungary.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; Takeda Pharmaceuticals USA, Inc. Lexington MA USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101707013%22">JBMR plus</searchLink> [JBMR Plus] 2023 May 31; Vol. 7 (7), pp. e10758. <i>Date of Electronic Publication: </i>2023 May 31 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101707013 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4039 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734039%22">24734039 </searchLink><i>NLM ISO Abbreviation: </i>JBMR Plus <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37457880
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jbm4.10758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e10758
    Titles:
      – TitleFull: A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ing SW
      – PersonEntity:
          Name:
            NameFull: Finkelman RD
      – PersonEntity:
          Name:
            NameFull: He P
      – PersonEntity:
          Name:
            NameFull: Khan AA
      – PersonEntity:
          Name:
            NameFull: Mannstadt M
      – PersonEntity:
          Name:
            NameFull: Rejnmark L
      – PersonEntity:
          Name:
            NameFull: Song I
      – PersonEntity:
          Name:
            NameFull: Takács I
      – PersonEntity:
          Name:
            NameFull: Wu Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 05
              Text: 2023 May 31
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4039
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JBMR plus
              Type: main
ResultId 1